Is meclizine safe for use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Meclizine Use During Pregnancy

Yes, meclizine can be taken during pregnancy and is considered safe based on extensive human epidemiological data showing no increased risk of major birth defects. 1

Safety Profile

The FDA drug label for meclizine clearly states that "epidemiological studies reporting on pregnancies exposed to meclizine have not identified an association between the use of meclizine during pregnancy and an increased risk of major birth defects" 1. This represents the highest quality evidence available—direct human data from multiple epidemiological studies.

Key Evidence Points:

  • Human data is reassuring: Large-scale epidemiological studies have consistently shown no increased risk of congenital malformations with meclizine use during pregnancy 1, 2
  • Swedish registry data: A particularly robust study of 16,536 women who used meclizine in early pregnancy found that delivery outcomes were actually better than expected, with reduced rates of congenital malformations, preterm birth, and low birth weight 2
  • First-generation antihistamines: Meclizine belongs to this class, which has been used safely for decades during pregnancy 3

Important Caveats

Animal Studies vs. Human Data

There is a notable discrepancy between animal and human data. Rat studies showed fetal malformations at doses approximately 2 times the maximum human dose (100 mg) on a body surface area basis 1, 4. However, this animal toxicity has not translated to humans in real-world use—a critical distinction that prioritizes actual human outcomes over theoretical animal concerns.

Clinical Recommendations

Meclizine is considered a first-choice antiemetic for nausea and vomiting in pregnancy based on its safety profile 5. When treating pregnancy-related nausea:

  • First-line option: Meclizine presents one of the lowest risks of teratogenicity among antiemetics 5
  • Dosing: Standard doses (25-100 mg daily) have been studied and found safe 1
  • Timing: Can be used throughout pregnancy, including the first trimester when organogenesis occurs 2

Practical Considerations

  • The beneficial effects observed in some studies (reduced preterm birth, better birth weights) are likely secondary to effective treatment of nausea and vomiting, preventing maternal dehydration and malnutrition 2
  • No data exists on meclizine in breast milk, so breastfeeding decisions should weigh maternal need against unknown infant exposure 1
  • Women with asthma, glaucoma, or prostate enlargement should use with caution due to anticholinergic effects 1

Bottom Line

Meclizine is safe for use during pregnancy based on extensive human epidemiological evidence. The animal study concerns have not materialized in human populations, and decades of clinical use support its safety profile. For pregnant women suffering from nausea, vomiting, or vertigo, the benefits of treatment clearly outweigh any theoretical risks, particularly given that untreated severe nausea can lead to dehydration and poor maternal nutrition—both harmful to fetal development.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.